For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250502:nRSB2926Ha&default-theme=true
RNS Number : 2926H Haleon PLC 02 May 2025
Haleon plc: Director/PDMR Shareholding
2 May 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by Persons
Discharging Managerial Responsibilities ("PDMRs").
On 2 May 2025, the Company received notification of the following transaction
as detailed below.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Asmita Dubey
2 Reason for the notification
a) Position/status Independent Non-Executive Director - PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Purchase of Ordinary Shares in the Company
c) Price(s) and volume(s)
Price(s) Volume(s)
£4.01 15,424
d) Aggregated information N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 2 May 2025
f) Place of the transaction London Stock Exchange (XLON)
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans six major categories - Oral Health, Vitamins, Minerals and Supplements
(VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin
Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on
trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com (http://www.haleon.com/)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBDGDUDUGDGUD